SVA [SINOVAC BIOTECH] 6-K: Sinovac Receives Nasdaq Deficiency Letter Regarding Audit Committee

[Sinovac Receives Nasdaq Deficiency Letter Regarding Audit Committee Requirement Press Release: Sinovac Biotech Co., Ltd. – Tue, Jan 24, 2012 4:05 PM EST BEIJING, Jan. 24, 2012 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (Nasdaq: SVA - News), a leading provider of vaccines in China, today announced that it received a letter dated January 18, 2012 from The Nasdaq Stock Market. Based] [Sinovac Commences the Phase III Clinical Trial for its EV71 Vaccine Against Hand, Foot and Mouth Disease Press Release: Sinovac Biotech Ltd. – Tue, Jan 10, 2012 8:00 AM EST BEIJING , Jan. 10, 2012 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (Nasdaq: SVA - News), a leading provider of biopharmaceutical products in China , announced today that the phase III clinical] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China Form 20-F x Form 40-F ¨ SINOVAC BIOTECH LTD. 6-K 1 v301323_6k.htm FORM 6-K]

By | 2016-03-24T01:26:07+00:00 February 6th, 2012|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments
Read More

SVA [SINOVAC BIOTECH] SC 13G/A: (Original Filing)

[1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Royce & Associates, LLC 52-2343049 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION New York NUMBER OF 5 SOLE VOTING POWER SHARES 1,749,629 BENEFICIALLY 6 SHARED VOTING POWER OWNED BY]

By | 2016-03-24T01:27:15+00:00 January 26th, 2012|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments
Read More

SVA [SINOVAC BIOTECH] SC 13G/A: 1 NAME OF REPORTING PERSON S.S. OR I.R.S.

[1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Royce & Associates, LLC 52-2343049 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION New York NUMBER OF 5 SOLE VOTING POWER SHARES 1,749,629 BENEFICIALLY 6 SHARED VOTING POWER OWNED BY]

By | 2016-03-24T01:28:22+00:00 January 26th, 2012|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments
Read More

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: (Original Filing)

[Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On January 12, 2012, Skystar Bio-Pharmaceutical Company (the “Company”) received staff determination from the Nasdaq Stock Market (“Exchange”) indicating that since the Company did not hold its annual shareholder meeting by December 31, 2011, the Company was not in compliance with Nasdaq]

By | 2016-03-01T04:53:49+00:00 January 19th, 2012|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments
Read More

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: Item 3.01 Notice of Delisting or Failure to

[Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On January 12, 2012, Skystar Bio-Pharmaceutical Company (the “Company”) received staff determination from the Nasdaq Stock Market (“Exchange”) indicating that since the Company did not hold its annual shareholder meeting by December 31, 2011, the Company was not in compliance with Nasdaq]

By | 2016-03-01T04:54:51+00:00 January 19th, 2012|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments
Read More

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: (Original Filing)

[Item 3.01Notice of Delisting or Failure totisfy antinued Listing Rule or Standard; Transfer of Listing. On January 12, 2012,ystar Bio-Pharmaceuticalmpany (thempany) received staff determination from the Nasdaq Stock Market (Exchange) indicating that since thempany did not hold its annual shareholder meeting by December 31, 2011, thempany was not inmpliance with Nasdaq Listing Rule 5620(a) and]

By | 2016-02-05T03:22:58+00:00 January 19th, 2012|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments
Read More

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: Item 3.01Notice of Delisting or Failure totisfy antinued

[Item 3.01Notice of Delisting or Failure totisfy antinued Listing Rule or Standard; Transfer of Listing. On January 12, 2012,ystar Bio-Pharmaceuticalmpany (thempany) received staff determination from the Nasdaq Stock Market (Exchange) indicating that since thempany did not hold its annual shareholder meeting by December 31, 2011, thempany was not inmpliance with Nasdaq Listing Rule 5620(a) and]

By | 2016-02-05T03:23:46+00:00 January 19th, 2012|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments
Read More
Skip to toolbar